In a remarkable medical achievement that underscores the power of timely diagnosis, precision oncology, and multidisciplinary teamwork, a 16-year-old girl has achieved complete remission from Primary Mediastinal B-Cell Lymphoma (PMBCL)—a rare, fast-growing, and potentially life-threatening blood cancer—at SGM Cancer Hospital, Sawangi (Meghe), Wardha.
PMBCL typically arises in the mediastinum and is known for its aggressive course, often compressing vital organs and spreading rapidly. In early 2025, the young patient presented with alarming symptoms including severe fatigue, progressive neck swelling, and breathlessness, caused by a large mediastinal mass exerting pressure on critical thoracic structures.
Recognizing the urgency, the oncology team at SGM Cancer Hospital initiated an expedited diagnostic workup. A core needle biopsy with immunohistochemistry (IHC) confirmed CD20-positive B-cell lymphoma, while baseline PET-CT imaging revealed a bulky, hypermetabolic mediastinal mass with extensive disease spread involving supradiaphragmatic lymph nodes, tonsils, lungs, adrenal glands, kidneys, and bone marrow—consistent with Stage IV PMBCL.
Despite the advanced stage, the medical team moved swiftly with evidence-based precision. The patient was started on the internationally validated R-DA-EPOCH chemotherapy regimen, a continuous 96-hour intravenous protocol shown in major clinical trials to deliver event-free survival rates exceeding 90%, while often eliminating the need for radiation therapy in young patients.
After just three cycles, an interim PET-CT scan demonstrated a complete metabolic response, confirming total eradication of active disease. Clinically, the transformation was dramatic: symptoms resolved, breathing normalized, and the patient returned to normal daily activities. She is currently continuing planned therapy to complete six cycles, aiming for a durable, long-term cure.
This success was spearheaded by Dr. Pradnya Modak, Assistant Professor, and Dr. Aditya Bhagwat, whose combined expertise in adolescent lymphoma management and medical oncology proved pivotal. The effort was further strengthened by Consultant Hematologist Dr. Rahul Arora, along with a highly committed team of oncology nurses and DM trainees who provided round-the-clock monitoring and care throughout the intensive treatment course.
“Her courage, combined with precise, protocol-driven oncology care, allowed us to overcome extensive mediastinal and systemic disease,” said Dr. Modak and Dr. Bhagwat in a joint statement. “This case reinforces that even aggressive cancers in young patients can be cured with early intervention, multidisciplinary coordination, and adherence to global standards—while sparing them from long-term radiation-related risks.”
The outcome closely mirrors landmark National Cancer Institute (NCI) trial results that have reshaped PMBCL treatment worldwide, emphasizing chemotherapy-driven cures and improved quality of life for adolescents and young adults.
Beyond an individual victory, this case carries a powerful public health message: early medical attention for persistent fatigue, unexplained swellings, or breathing difficulty in adolescents can be life-saving.
With this milestone, SGM Cancer Hospital, Wardha, continues to establish itself as a center of excellence in oncology care in Central India—delivering world-class outcomes through clinical rigor, collaboration, and compassion.
This story stands as a testament to hope, science, and the transformative impact of unified medical expertise in the fight against cancer.
👉 Click here to read the latest Gujarat news on TheLiveAhmedabad.com